BioAdaptives, Inc. (BDPT)

Market Cap	561.47K
Revenue (ttm)	675.00
Net Income (ttm)	-789.59K
Shares Out	9.05M
EPS (ttm)	-0.09
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Average Volume	14,273
Open	0.0666
Previous Close	0.0621
Day's Range	0.0650 - 0.0682
52-Week Range	0.0050 - 0.1800
Beta	0.73
RSI	54.05
Earnings Date	May 19, 2025

About BioAdaptives

BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers PluriPain, a fast acting long lasting natural pain relief formulation; PrimiLungs; MindNMemory, a nootropic formulation that enhances memory, focus, mental clarity, and endurance; PrimiSleep, a natural soporific that aids relaxation and sleep quality; Cell Rejuven that increases energy and mobility and resistance t...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2013
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: BDPT

Financial Performance

In 2024, BioAdaptives's revenue was $12,669, a decrease of -55.65% compared to the previous year's $28,565. Losses were -$899,161, 26.2% more than in 2023.